Posted by Michael Wonder on 06 Apr 2023
Life changing cystic fibrosis treatment now available to children 6 years and above
6 April 2023 - From 1 May 2023, children aged 6 to 11 with cystic fibrosis will have access to the medicine Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor), through the Pharmaceutical Benefits Scheme.
The listing of Trikafta for this age group will be a game changer for children living with cystic fibrosis and their families.
